Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-07-19
2005-07-19
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C435S013000, C435S069600, C435S320100, C435S253300, C435S242000, C536S023400, C536S023500
Reexamination Certificate
active
06919311
ABSTRACT:
Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
REFERENCES:
patent: 5364771 (1994-11-01), Lollar et al.
Pipe S. W. (1996) Factor VIII C2 domain missense mutations exhibit trafficking of biologically functional proteins. J Biol Chem. vol. 271, pp. 25671-25676.
Eaton, D. L. et al. (1986) Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry. vol. 25, pp. 8343-8347.
Lenting P. J. (1999) The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein. J Biol Chem. vol. 274, pp. 23734-23739.
Liu, M. L. et al. (2000) Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure. Blood vol. 96, pp. 979-987.
Schwarz, H. P. et al. (2000) Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice. Blood. vol. 95, pp. 1703-1708.
Willnow, T. E. et al. (1999) Lipoprotein receptors: new roles for ancient proteins.Nature Cell Biol. vol. 1, pp. E157-E162. Review.
Lenting Petrus Johannes
Mertens Koenraad
Pannekoek Hans
Scheiflinger Friedrich
Schwarz Hans-Peter
Carlson Karen Cochrane
Heller Ehrman White & McAuliffe
Liu Samuel Wei
Stichting Sanquin Bloedvoorziening
LandOfFree
Factor VII polypeptide having factor VII:C activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor VII polypeptide having factor VII:C activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor VII polypeptide having factor VII:C activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3397779